UBS Group AG - BURNING ROCK BIOTECH LTD ownership

BURNING ROCK BIOTECH LTD's ticker is BNR and the CUSIP is 12233L107. A total of 28 filers reported holding BURNING ROCK BIOTECH LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of BURNING ROCK BIOTECH LTD
ValueSharesWeighting
Q3 2023$1,673
-79.6%
1,725
-40.8%
0.00%
Q1 2023$8,191
+94.2%
2,915
+55.5%
0.00%
Q4 2022$4,217
-95.5%
1,874
-94.1%
0.00%
Q2 2022$93,000
+304.3%
31,720
+1169.8%
0.00%
Q1 2022$23,000
+76.9%
2,498
+83.3%
0.00%
Q4 2021$13,000
-99.0%
1,363
-98.2%
0.00%
Q3 2021$1,358,000
-34.2%
75,962
+8.4%
0.00%
-100.0%
Q2 2021$2,064,000
+22833.3%
70,046
+16984.4%
0.00%
Q4 2020$9,000
-89.9%
410
-87.5%
0.00%
Q2 2020$89,0003,2850.00%
Other shareholders
BURNING ROCK BIOTECH LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Asymmetry Capital Management, L.P. 217,728$5,030,0002.29%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 1,685,908$38,944,0002.07%
Casdin Capital, LLC 1,922,150$44,402,0001.32%
Orbimed Advisors 4,161,675$96,135,0000.84%
INDUS CAPITAL PARTNERS, LLC 144,580$3,340,0000.52%
Aspex Management (HK) Ltd 486,418$11,236,0000.44%
HSG Holding Ltd 212,121$4,900,0000.41%
MASSACHUSETTS INSTITUTE OF TECHNOLOGY 15,100$349,0000.39%
HAMILTON LANE ADVISORS LLC 44,416$1,026,0000.38%
Monashee Investment Management LLC 80,000$1,848,0000.24%
View complete list of BURNING ROCK BIOTECH LTD shareholders